Mesalamine

Overview

Mesalamine is an anti-inflammatory drug used to treat inflammatory bowel diseases, such as ulcerative colitis. It works by inhibiting the production of substances in the lining of the colon that cause inflammation.

API suppliers (26)

Suppliers of Mesalamine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Zydus Lifesciences LimitedIndia2 active DMF
• ERREGIERRE SPAItaly2 active DMF
• CHEMI SPAItaly1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• SOLARA ACTIVE PHARMA SCIENCES LTD1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• SOLARA ACTIVE PHARMA SCIENCES LTD1 active DMF
• CHEMI SPAItaly1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Pharmaron Beijing Co., Ltd.China1 active DMF
• Ipca Laboratories LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Pharmaron Beijing Co., Ltd.China1 active DMF
• SOLARA ACTIVE PHARMA SCIENCES LTD1 active DMF
• Ipca Laboratories LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Ipca Laboratories LimitedIndia1 active DMF
• Pharmaron Beijing Co., Ltd.China1 active DMF
• CORDEN PHARMA BERGAMO SPAItaly
• SIGNA SA DE CV
• LUPIN MANUFACTURING SOLUTIONS LTD
• Lupin LimitedIndia
• SIMS SRL
• BEC CHEMICALS PRIVATE LTD
• Dr. Reddy's Laboratories Ltd.India

Showing 25 of 26 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (39 approved US products), the latest listed US patent on Mesalamine expires 30 Apr 2030. Generic API sourcing typically opens up once these lapse.

Therapeutic areas